↓ Skip to main content

miR-488 acts as a tumor suppressor gene in gastric cancer

Overview of attention for article published in Tumor Biology, January 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
14 Mendeley
Title
miR-488 acts as a tumor suppressor gene in gastric cancer
Published in
Tumor Biology, January 2016
DOI 10.1007/s13277-015-4645-y
Pubmed ID
Authors

Yan Zhao, Guifang Lu, Xiquan Ke, Xinlan Lu, Xin Wang, Hongxia Li, Mudan Ren, Shuixiang He

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that modulate development, cell proliferation, and apoptosis. The deregulated expression of microRNAs is found in carcinogenesis including gastric cancer (GC). In this study, we showed that the expression levels of miR-488 were downregulated in GC tissues compared to in non-tumor tissues. In addition, the expression of miR-488 was also lower in GC cell lines in contrast with the gastric epithelial cell line (GES). In addition, the expression level of miR-488 was negatively correlated with the TNM stage in GC patients, and lower miR-488 expression was found in tumors with advanced TNM stage. The ectopic expression of miR-488 suppressed the GC cell proliferation, cell cycle, colony information, and migration. PAX6 was identified as a direct target gene of miR-488 in HGC-27. Moreover, we found that the expression level of PAX6 was upregulated in the GC tissues compared with the non-tumor tissues. The PAX6 expression level was correlated with the cancer TNM stage, and higher PAX6 expression was found in tumors with advanced TNM stage. Furthermore, there was an inverse correlation between PAX6 and miR-488 expression levels in GC tissues. Therefore, these studies demonstrated that miR-488 might act as a tumor suppressor miRNA in the development of GC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 29%
Student > Ph. D. Student 1 7%
Professor 1 7%
Student > Master 1 7%
Student > Postgraduate 1 7%
Other 0 0%
Unknown 6 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 21%
Medicine and Dentistry 2 14%
Agricultural and Biological Sciences 1 7%
Nursing and Health Professions 1 7%
Unknown 7 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2016.
All research outputs
#20,300,248
of 22,837,982 outputs
Outputs from Tumor Biology
#1,834
of 2,622 outputs
Outputs of similar age
#330,512
of 393,663 outputs
Outputs of similar age from Tumor Biology
#184
of 288 outputs
Altmetric has tracked 22,837,982 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,622 research outputs from this source. They receive a mean Attention Score of 2.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,663 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 288 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.